Citigroup Inc Iovance Biotherapeutics, Inc. Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 409,565 shares of IOVA stock, worth $987,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares

409,565

Previous 714,851 42.71%

Holding current value

$987,051

Previous $1.23 Million 27.75%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$1.7 - $3.97 $518,986 - $1.21 Million	-305,286 Reduced 42.71%	409,565 $888,000
Q2 2025 Aug 11, 2025	BUY	$1.66 - $3.61 $293,054 - $637,305	176,539 Added 32.79%	714,851 $1.23 Million
Q1 2025 May 12, 2025	BUY	$3.33 - $7.79 $180,719 - $422,763	54,270 Added 11.21%	538,312 $1.79 Million
Q4 2024 Feb 12, 2025	BUY	$7.17 - $12.28 $1.97 Million - $3.38 Million	275,278 Added 131.86%	484,042 $3.58 Million
Q3 2024 Nov 12, 2024	BUY	$7.28 - $11.9 $513,836 - $839,925	70,582 Added 51.08%	208,764 $1.96 Million
Q2 2024 Aug 12, 2024	SELL	$7.78 - $14.19 $3.13 Million - $5.7 Million	-401,713 Reduced 74.41%	138,182 $1.11 Million
Q1 2024 May 10, 2024	SELL	$7.59 - $17.47 $1.62 Million - $3.74 Million	-214,013 Reduced 28.39%	539,895 $8 Million
Q4 2023 Feb 09, 2024	SELL	$3.3 - $8.89 $605,586 - $1.63 Million	-183,511 Reduced 19.58%	753,908 $6.13 Million
Q3 2023 Nov 09, 2023	BUY	$4.44 - $8.79 $1.38 Million - $2.73 Million	310,118 Added 49.44%	937,419 $4.27 Million
Q2 2023 Aug 10, 2023	SELL	$5.36 - $9.06 $3.41 Million - $5.76 Million	-635,344 Reduced 50.32%	627,301 $4.42 Million
Q1 2023 May 11, 2023	BUY	$5.53 - $8.22 $4.11 Million - $6.11 Million	743,295 Added 143.12%	1,262,645 $7.71 Million
Q4 2022 Feb 09, 2023	SELL	$5.62 - $10.0 $285,630 - $508,240	-50,824 Reduced 8.91%	519,350 $3.32 Million
Q3 2022 Nov 10, 2022	BUY	$9.53 - $13.11 $864,390 - $1.19 Million	90,702 Added 18.92%	570,174 $5.46 Million
Q2 2022 Aug 10, 2022	BUY	$6.38 - $18.33 $2.48 Million - $7.13 Million	389,174 Added 430.99%	479,472 $5.29 Million
Q1 2022 May 12, 2022	SELL	$12.38 - $19.1 $1.88 Million - $2.9 Million	-151,661 Reduced 62.68%	90,298 $1.5 Million
Q4 2021 Feb 10, 2022	BUY	$16.55 - $27.63 $1.97 Million - $3.29 Million	119,208 Added 97.11%	241,959 $4.62 Million
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $2.5 Million - $3.27 Million	122,751 New	122,751 $3.03 Million

Others Institutions Holding IOVA

# of Institutions

281

Shares Held

222M

Call Options Held

1.07M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $380M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account